Centrum Onkologii im. prof. Franciszka Lukaszczyka w Bydgoszczy

Bydgoszcz 85796

0 studies enrolling now · 7 studies all time

What they study most

Advanced or Metastatic Solid Tumors, Carcinoma, Non-Small-Cell Lung, Chemotherapy-induced Thrombocytopenia, Colorectal Cancer, Head and Neck Squamous Cell Carcinoma, Melanoma, Melanoma (Skin), Melanoma Stage III, Melanoma Stage IV, Solid Tumor

Studies at this site

• Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast Cancer — Running, not enrolling
• A Study of TAK-981 Given With Pembrolizumab in Participants With Select Advanced or Metastatic Solid Tumors — Completed
• Study of Magrolimab Combination Therapy in Patients With Head and Neck Squamous Cell Carcinoma — Stopped early
• Study of Magrolimab in Patients With Solid Tumors — Stopped early
• Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence — Stopped early
• A Study of Tislelizumab (BGB-A317) Plus Chemoradiotherapy Followed by Tislelizumab Monotherapy in Newly Diagnosed, Stage III Subjects With Locally Advanced, Unresectable Non-small Cell Lung Cancer — Stopped early
• Efficacy and Safety of Simtuzumab (SIM) With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma — Stopped early